Clinical Trial Update: Venous Thromboembolism in Myotonic Dystrophy Type 1 [NA]

View source ↗

Summary

The clinical trial NCT03424460 evaluating venous thromboembolism risk in patients with Myotonic Dystrophy Type 1 has completed. The sponsor is Assistance Publiq…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myotonic Dystrophy Type

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Myotonic Dystrophy 1 | NA | Status: COMPLETED